Molecular mechanism of RIPK1 and caspase-8 in homeostatic type I interferon production and regulation

被引:11
|
作者
Wang, Yaqiu [1 ]
Karki, Rajendra [1 ]
Mall, Raghvendra [1 ]
Sharma, Bhesh Raj [1 ]
Kalathur, Ravi C. [2 ]
Lee, SangJoon [1 ]
Kancharana, Balabhaskararao [1 ]
So, Matthew [1 ]
Combs, Katie L. [1 ]
Kanneganti, Thirumala-Devi [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN 38105 USA
来源
CELL REPORTS | 2022年 / 41卷 / 01期
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; DOMAIN KINASE RIP; INNATE IMMUNITY; INFLAMMASOME ACTIVATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; KEY REGULATOR; CELL-DEATH; LYMPHOCYTE; CLEAVAGE;
D O I
10.1016/j.celrep.2022.111434
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Type I interferons (IFNs) are essential innate immune proteins that maintain tissue homeostasis through tonic expression and can be upregulated to drive antiviral resistance and inflammation upon stimulation. However, the mechanisms that inhibit aberrant IFN upregulation in homeostasis and the impacts of tonic IFN produc-tion on health and disease remain enigmatic. Here, we report that caspase-8 negatively regulates type I IFN production by inhibiting the RIPK1-TBK1 axis during homeostasis across multiple cell types and tissues. When caspase-8 is deleted or inhibited, RIPK1 interacts with TBK1 to drive elevated IFN production, leading to heightened resistance to norovirus infection in macrophages but also early onset lymphadenopathy in mice. Combined deletion of caspase-8 and RIPK1 reduces the type I IFN signaling and lymphadenopathy, highlighting the critical role of RIPK1 in this process. Overall, our study identifies a mechanism to constrain tonic type I IFN during homeostasis which could be targeted for infectious and inflammatory diseases.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Human Rhinovirus 3C protease cleaves RIPK1, concurrent with caspase 8 activation
    Croft, Sarah N.
    Walker, Erin J.
    Ghildyal, Reena
    SCIENTIFIC REPORTS, 2018, 8
  • [22] Novel Roles for Caspase-8 in IL-1β and Inflammasome Regulation
    Gurung, Prajwal
    Kanneganti, Thirumala-Devi
    AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (01): : 17 - 25
  • [23] cFLIPL acts as a suppressor of TRAIL- and Fas- initiated inflammation by inhibiting assembly of caspase-8/FADD/RIPK1 NF-KB-activating complexes
    Davidovich, Pavel
    Higgins, Catherine A.
    Najda, Zaneta
    Longley, Daniel B.
    Martin, Seamus J.
    CELL REPORTS, 2023, 42 (12):
  • [24] A new path to IL-1β production controlled by caspase-8
    Jeremy Dupaul-Chicoine
    Maya Saleh
    Nature Immunology, 2012, 13 : 211 - 212
  • [25] A new path to IL-1β production controlled by caspase-8
    Dupaul-Chicoine, Jeremy
    Saleh, Maya
    NATURE IMMUNOLOGY, 2012, 13 (03) : 211 - 212
  • [26] Metabolic regulation of type I interferon production
    O'Carroll, Shane M.
    Henkel, Fiona D. R.
    O'Neill, Luke A. J.
    IMMUNOLOGICAL REVIEWS, 2024, 323 (01) : 276 - 287
  • [27] The Regulation of Type I Interferon Production by Paramyxoviruses
    Goodbourn, Stephen
    Randall, Richard E.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2009, 29 (09): : 539 - 547
  • [28] Caspase-8 deficiency in mouse embryos triggers chronic RIPK1-dependent activation of inflammatory genes, independently of RIPK3
    Tae-Bong Kang
    Ju-Seong Jeong
    Seung-Hoon Yang
    Andrew Kovalenko
    David Wallach
    Cell Death & Differentiation, 2018, 25 : 1107 - 1117
  • [29] Caspase-8 deficiency in mouse embryos triggers chronic RIPK1-dependent activation of inflammatory genes, independently of RIPK3
    Kang, Tae-Bong
    Jeong, Ju-Seong
    Yang, Seung-Hoon
    Kovalenko, Andrew
    Wallach, David
    CELL DEATH AND DIFFERENTIATION, 2018, 25 (06): : 1107 - 1117
  • [30] The neurotoxicant PCB-95 by increasing the neuronal transcriptional. repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death
    Guida, Natascia
    Laudati, Giusy
    Serani, Angelo
    Mascolo, Luigi
    Molinaro, Pasquale
    Montuori, Paolo
    Di Renzo, Gianfranco
    Canzoniero, Lorella M. T.
    Formisano, Luigi
    BIOCHEMICAL PHARMACOLOGY, 2017, 142 : 229 - 241